Newscenter Media News Personalized therapy enhances survival rates for patients with CLL leukemia. A phase III trial conducted by the University of Leeds discovered that personalized treatment for…
Check Also
Jeff Bezos-backed Perplexity AI submits new bid for TikTok’s US operations
Jeff Bezos-backed Perplexity AI has sent a revised proposal to ByteDance, the parent firm of …